CNS drug development is facing a new era, thanks to huge strides in neuroscience innovation, including advances in blood-brain barrier transport, CSF administration, and device-mediated delivery, to solve the field’s most pressing challenge: access to the brain.

Riding the wave of drug delivery innovation, the industry’s definitive 6th CNS Drug Delivery Summit returned in 2024, showcasing breakthrough progress in receptor-mediated transcytosis, CSF dose escalation, quantifying brain distribution, BBB modeling, CED and FUS technology, emerging modalities including LNPs, and more.

100+ of your industry colleagues from the likes of Roche, Biogen, UCB, JCR, Ionis, Janssen, Eli Lilly, Alector, Novartis, Eisai, Sanofi, and Takeda united to discover and translate safer, more effective brain delivery technologies to change the trajectory of CNS drug development.